References
- Abel K, Ahven A, Denissov G, Derman N, Hansson L, Kalikova N, Kiipus M, Paimre M, Talu A. 2002. National Report on Drug Situation in Estonia 2001; Estonian Drug Monitoring Centre, Tallinn: National Focal Point.
- Abel K, Talu A, Neuman A, Ahven A, Denissov G, Laastik L. 2005. National Report to the EMCDDA by the Reitox National Focal Point. “ESTONIA” New Development, Trends and In-depth Information on Selected Issues.
- Aceijas C, Stimson GV, Hickman M, Rhodes T. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 2004; 18: 2295–2303
- Cormack RM. Problems with using capture–recapture in epidemiology: An example of a measles epidemic. Jouranl of Clinical Epidemiology 1999; 52: 909–914
- Cormack RM, Chang YF, Smith GS. Estimating deaths from industrial injury by capture-recapture: A cautionary tale. International Journal of epidemiology 2000; 29: 1053–1059
- Denissov G (2004) Lisbon EMCDDA DRD expert meeting. 24–25 November, 2005
- http://www.tervisekaitse.ee/tkuus.php, ?msgid = 3013, Estonian Health Protection Inspectorate
- http://www.sm.ee/, Estonian Health Statistics [Accessed 2005 November 11].
- Evans MA, Bonett DG. Bias recduction for multiple-recapture estimators of closed population size. Biometrics 1994; 50: 388–395
- Hay G, McKeganey N. 2003. Enumeration in the Baltic Sea Region. Report to the Synergy Project.
- Hickman M, Sutcliffe H, Sondhi A, Stimson GV. Surveillance of problem drug use in the UK: A review of a Regional Drug Misuse Database. Jouranl of Public Health Medicine 1999; 21(3)271–277
- Hook EB, Regal RR. Capture-recapture methods in epidemiology: Methods and limitations. Epidemiologic Reviews 1995; 17(2)243–264
- http://www.eurohiv.org/reports/report_73/pdf/text.pdf, (25.02. 2007)
- Pisani E. 2003. Estimating the Size of Populations at Risk for HIV. Issues and methods. UNAIDS/IMPACT/FHI 2003. ISBN 974-91495-0-5.
- Platt L, Bobrova N, Rhodes T, Uuskula A, Parry JV, Ruutel K, Talu A, Abel K, Rajaleid K, Judd A. 2006. High HIV prevalence among injecting drug users in Estonia: Implications for understanding the risk environment. AIDS 20(16):2120–2123.
- http://www.pol.ee/index.php, ?id = 476, Politseiameti arenguosakond. Registreeritud ja avastatud kuriteod Eestis. 2004 [Accessed 2005 November 19]
- Priimägi L, Kremerman I, Tefanova V, Tallo T, Osadtsaja G. Study on hepatitis C and hepatitis B infected intravenous drug users. Eesti Arst 1998; 6: 521–523
- Report on the global AIDS epidemic, May 2006. UNAIDS.
- http://www.ltkh.ee/failid/HIV_infitseeritud_elukoha_j_rgi_1987_2005.pdf, State HIV/AIDS Reference Laboratory
- www.stat.ee, Statictical Office of Estonia [Accessed 2006 January 25]
- Talu A, Abel K, Ahven A, Neuman A, Laastik L. 2004. Estonia Drug Situation. National Report to the EMCDDA.
- Tefanova V, Krupskaja L, Kikos G, Tallo T, Priimägi L. Study on hepatitis B and hepatitis C epidemiology in Tallinn. Eesti Arst 1998; 6: 552–553
- Uusküla A, Abel K, Rajaleid K, Rüütel K, Talu A, Fischer K, Boborova N. 2005. HIV and risk behaviour among injecting drug users in two cities (Tallin, Kohtla-järve) in Estonia. Project Report to GF/NIHD.
- Uusküla A, Heimer R, DeHovitz J, Fischer K, McNutt LA. Surveillance of HIV, HBV, and HCV in an Estonian injection drug using population: Sensitivity and specificity of testing syringes for public health surveillance. JID 2006; 193(3)455–457
- Uusküla A, Kalikova N, Zilmer K, Tammai L, DeHovitz J. The role of injecting drug use in the emergence of HIV in Estonia. International Journal of Infectious Diseases 2002; 6: 23–27